P. Colombatto Et Al. , "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib," CANCERS , vol.13, no.9, 2021
Colombatto, P. Et Al. 2021. Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. CANCERS , vol.13, no.9 .
Colombatto, P., DEMİRTAŞ, C. Ö., Ricco, G., Civitano, L., Boraschi, P., Scalise, P., ... Cavallone, D.(2021). Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib. CANCERS , vol.13, no.9.
Colombatto, Piero Et Al. "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib," CANCERS , vol.13, no.9, 2021
Colombatto, Piero Et Al. "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib." CANCERS , vol.13, no.9, 2021
Colombatto, P. Et Al. (2021) . "Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib." CANCERS , vol.13, no.9.
@article{article, author={Piero Colombatto Et Al. }, title={Modeling Hepatocellular Carcinoma Cells Dynamics by Serological and Imaging Biomarkers to Explain the Different Responses to Sorafenib and Regorafenib}, journal={CANCERS}, year=2021}